← Open Payments lookup

RICHARD NOEL: Open Payments

NPI 1225058852 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$918 in 50 payments from 8 companies in 2025. Trend: 2023 $890 · 2024 $1,603 · 2025 $918

Food & beverage: $918
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.9$287
Otsuka America Pharmaceutical, Inc.14$225
Neurocrine BioSciences, Inc.10$158
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$157
Alkermes, Inc.2$41
Janssen Pharmaceuticals, Inc1$27
Teva Pharmaceuticals USA, Inc.1$20
Corium, LLC1$3

Products named: COBENFY, INGREZZA, CAPLYTA, ABILIFY ASIMTUFII, REXULTI, ARISTADA, INVEGA SUSTENNA, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.